CONRIG PHARMA ApS: Financial statements 2023
CVR: 33373236
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -506,147 and a net result of DKK -510,872 compared with DKK 1,244,502 the year before. Equity in the 2023 report amounted to DKK -101,847.
- Gross Profit
- DKK -506,147
- Profit/Loss
- DKK -510,872
- Equity
- DKK -101,847
- Total Assets
- DKK 38,530
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -506 t. | -511 t. | -102 t. | - |
| 2022 | - | 1.3 mio. | 1.2 mio. | 409 t. | - |
| 2021 | - | -246 t. | -308 t. | -1.7 mio. | - |
| 2020 | - | -555 t. | -604 t. | -1.4 mio. | - |
| 2019 | - | -165 t. | -198 t. | -793 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CONRIG PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,265,932, and the net result was DKK 1,244,502.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Lars Christer Fredrik Fåhraeus and Snickar Karl Johan Tobieson. The board consists of Lars Christer Fredrik Fåhraeus, Niels Skjærbæk and Snickar Karl Johan Tobieson. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.